United States · FDA National Drug Code directory
Levothyroxine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-885_b76cd786-4b5c-4f96-bbbf-a7399d50fb27
- Product NDC
- 63323-885
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20180529
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — 20 ug/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-885-12) / 5 mL in 1 VIAL, SINGLE-DOSE · 63323-885-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →